Latest News

Cannasouth Limited (NZX:CBD) is pleased to announce that it has signed a binding term sheet (“Term Sheet”) with the Board of ...

Helius Therapeutics will soon launch THC containing medicines that are both grown and made in New Zealand. Read more ...

Helius Therapeutics has received Good Agricultural and Collection Practice (GACP) certification at its purpose-built medicinal cannabis facility in East Tamaki, Auckland. ...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) certificate ...

New Plymouth businessman Philip Brown has been appointed chairman of NZX-listed medicinal cannabis company Greenfern Industries Limited. The role was vacated ...

Rua is now inviting specific East Coast kura to nominate students for our undergraduate scholarships as well as inviting all postgraduate ...

Leading Bay of Plenty-based medicinal cannabis company Eqalis has successfully applied for and received its Good Manufacturing Practice (GMP) license, allowing ...

Greenfern Industries is pleased to announce that recently received overseas lab testing results of their medicinal cannabis flower starting material has ...

Rua Bioscience Limited (NZX: RUA) formally announced today that it has received its first order via its German distributor Nimbus Health, ...

Rua Bioscience’s cultivation partnership with Australian-based Cann Group is making significant headway; the two companies achieving key milestones this week. read ...

For the first time in New Zealand, Kiwi patients can now be prescribed New Zealand-grown, New Zealand-made cannabis medicine. Read more ...

“This is great news for many patients who have long sought legal access to both New Zealand-grown and made medicinal cannabis ...